As of 2026-09-20, the Relative Valuation of Crescita Therapeutics Inc (CTX.TO) is 0.02 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.79 CAD, the upside of Crescita Therapeutics Inc based on Relative Valuation is -97.1%.
The range of the Relative Valuation is (0.00) - 0.20 CAD.
| Range | Selected | |
| Trailing P/E multiples | 0.2x - 1.1x | 0.2x |
| Forward P/E multiples | 6.5x - 32.3x | 8.1x |
| Fair Price | (0.00) - 0.20 | 0.02 |
| Upside | -100.3% - -75.0% | -97.1% |
| Date | P/E |